Caris Life Sciences, Inc Common Stock

Yahoo Finance • 9 days ago

Caris Life Sciences, Inc. (CAI) Soars 81% YoY with $181M Q2 Revenue

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Caris Life Sciences, Inc. is one of them. Caris Life Sciences, Inc. (NASDAQ:CAI) is advancing its position as a leader in precision medicine by combining... Full story

Yahoo Finance • 10 days ago

CAI and Valkit.ai Form Strategic Partnership to Advance Gen2 AI-Augmented Validation (DVT) in Life Sciences

Indianapolis, IN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- CAI, a global leader in operational readiness and excellence for life sciences and mission critical facilities, today announced a strategic partnership with Valkit.ai, a fast-growing i... Full story

Yahoo Finance • 22 days ago

CAI Achieves SOC 2 Type II Certification, Strengthening Trust of Data Management

ALLENTOWN, Pa., Sept. 18, 2025 (GLOBE NEWSWIRE) -- CAI, a global services firm, today announced it achieved the System and Organization Controls (SOC) 2 Type II certification, validating its ability to protect sensitive client data amids... Full story

Yahoo Finance • 22 days ago

Strong Performance Lifted Caris Life Sciences (CAI) in Q2

ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter.... Full story

Yahoo Finance • 29 days ago

Caris Life Sciences, Inc. (CAI) Secures FDA Nod for Revolutionary Tumor Profiling Test

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Caris Life Sciences, Inc. stands tenth among them. Caris Life Sciences, Inc. (NASDAQ:CAI) is a biotech company that is driven by its breakt... Full story

Yahoo Finance • 2 months ago

Can AI make clinical trials better?

Investing.com -- Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number of novel drug approvals... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK buys Archer Aviation, sells Kratos Defense stock

Cathie Wood’s ARK ETFs have made notable moves in the market on Tuesday, 12 August 2025, with a series of buys and sells that signal the investment firm’s strategic adjustments. The most significant transaction of the day involved the sale... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK buys Tesla, sells Coinbase in latest trades

Cathie Wood’s ARK ETFs have made a series of notable trades on Tuesday, 15 July 2025, with Tesla Inc (NASDAQ:TSLA) and Coinbase Global Inc (NASDAQ:COIN) taking center stage as the most significant transactions by dollar value. The invest... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK sells Roku, buys Caris Life Sciences stock

Cathie Wood’s ARK ETFs have published their daily trades for Monday, July 14th, 2025, revealing a mix of strategic buy and sell actions across various sectors. Leading the trades was the sale of Roku Inc (NASDAQ:ROKU) stock, with a combi... Full story

Yahoo Finance • 3 months ago

Caris Life Sciences stock initiated with Buy rating at BTIG on precision oncology leadership

Investing.com - BTIG initiated coverage on Caris Life Sciences Inc (NASDAQ:CAI) with a Buy rating and a price target of $38.00 on Monday, representing significant upside from the current price of $26.51. According to InvestingPro data, a... Full story

Yahoo Finance • 3 months ago

BofA Securities initiates coverage on Caris Life Sciences stock with Buy rating

Investing.com - BofA Securities initiated coverage on Caris Life Sciences Inc (NASDAQ:CAI) with a Buy rating and a price target of $31.00 on Sunday, representing a potential 17% upside from the current price of $26.51. According to Inves... Full story

Yahoo Finance • 3 months ago

Catalyst Watch: Bank earnings rush, OPEC report, Tesla EVs get Grok, and Superman at the box office

[Wall Street sign in Lower Manhattan, NYC] georgeclerk Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MO... Full story

Yahoo Finance • 3 months ago

Will Insiders Be Tempted To Buy More CAI At The New 52-Week Low?

In trading on Monday, shares of Caris Life Sciences Inc (Symbol: CAI) touched a new 52-week low of $25.40/share. That's a $5.30 share price drop, or -17.26% decline from the 52-week high of $30.70 set back on 06/20/2025. Large percentage... Full story